Clinical Trial Update: Study With Atezolizumab in Combination With Trastuzumab and Vinorelbine in HER2-positive Advanced/Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

This clinical trial update covers a Phase 2 study of atezolizumab in combination with trastuzumab and vinorelbine for HER2-positive advanced or metastatic breas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• Trastuzumab (trastuzumab)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: SOLTI Breast Cancer Research Group | Conditions: Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING